Stevanato Group S.p.A. earnings per share and revenue
On Nov 06, 2025, STVN reported earnings of 0.14 USD per share (EPS) for Q3 25, beating the estimate of 0.12 USD, resulting in a 10.67% surprise. Revenue reached 303.20 million, compared to an expected 296.20 million, with a 2.36% difference. The market reacted with a -2.36% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of 0.17 USD, with revenue projected to reach 340.59 million USD, implying an increase of 21.43% EPS, and increase of 12.33% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were Stevanato Group S.p.A.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Stevanato Group S.p.A. reported EPS of $0.14, beating estimates by 10.67%, and revenue of $303.20M, 2.36% above expectations.
How did the market react to Stevanato Group S.p.A.'s Q3 2025 earnings?
The stock price moved down -2.36%, changed from $25.00 before the earnings release to $24.41 the day after.
When is Stevanato Group S.p.A. expected to report next?
The next earning report is scheduled for Mar 05, 2026.
What are the forecasts for Stevanato Group S.p.A.'s next earnings report?
Based on 12
analysts, Stevanato Group S.p.A. is expected to report EPS of $0.17 and revenue of $340.59M for Q4 2025.